Atorvastatin Recall: Popular Cholesterol Medicine Pulled From Pharmacies

Over 140,000 bottles of a prescription statin have been pulled from the market due to “failed dissolution specifications,” according to a report by the U.S. Food and Drug Administration (FDA). Ascend Laboratories, based in New Jersey, recalled Atorvastatin Calcium, a generic version of Lipitor, manufactured by Alkem Laboratories of India and distributed across the country. The recall covers tablets in 90-count, 500-count, and 1,000-count bottles with expiration dates extending to February 2027.Atorvastatin Recall: Why Is The Popular Cholesterol Medicine Being Recalled?On October 10, 2025, the FDA classified the recalled drug as a Class II recall. This classification means the medication could cause “temporary or medically reversible adverse health effects,” though the likelihood of serious